INTELLIA THERAPEUTICS, INC.
LEI 5493002T5BCPE5DZC723 · QID Q54621387
Industry: In Vitro & In Vivo Diagnostic Substances
Time series: Revenue by fiscal year · Net Income by fiscal year
| Fact | Value | Period | Source |
|---|---|---|---|
| entity_legal_form | {"value": "XTIQ", "elf_code": "XTIQ"} | gleif | |
| headquarters_address | {"city": "Cambridge", "region": "US-MA", "street": "130 Brookline Street; Suite 201", "cou | gleif | |
| legal_address | {"city": "WILMINGTON", "region": "US-DE", "street": "c/o THE CORPORATION TRUST COMPANY, CO | gleif | |
| legal_jurisdiction | {"value": "US-DE", "scheme": "ISO 3166"} | gleif | |
| legal_name | {"lang": "en", "value": "INTELLIA THERAPEUTICS, INC."} | gleif | |
| observed_web_domain | {"via": "wikidata:P856", "domain": "intelliatx.com"} | robots_obs | |
| registration_status | {"entity_status": "ACTIVE", "lei_registration_status": "ISSUED"} | gleif | |
| website | {"qid": "Q54621387", "url": "http://intelliatx.com/", "via": "wikidata"} | wikidata |
Cite as: FACTANKER, https://factanker.com/entity/9699cb5b-201d-4736-ade2-31d1b927a578